Literature DB >> 24570280

Diagnostic profiles of patients with late-onset Creutzfeldt-Jakob disease differ from those of younger Creutzfeldt-Jakob patients: a historical cohort study using data from the German National Reference Center.

André Karch1, Lena Maria Raddatz, Claudia Ponto, Peter Hermann, David Summers, Inga Zerr.   

Abstract

In contrast to other neurodegenerative diseases, sporadic Creutzfeldt-Jakob disease (sCJD) is rarely diagnosed in patients older than 75 years. Data describing the characteristics of sCJD in the very old are rare and inconclusive. Therefore, a historical cohort study was designed to evaluate clinical, cerebrospinal fluid (CSF), electroencephalography (EEG), and magnetic resonance imaging (MRI) features of this group. Patients older than 75 years identified via the German surveillance program from 2001 to 2012 (n = 73) were compared to a random subsample of sCJD patients younger than 75 (n = 73) from the same time period using an historical cohort design. Older patients showed a faster disease progression represented by an earlier point of diagnosis and a shorter survival time (p < 0.001). In the early stages of disease, older patients presented slightly more often with dementia (p = 0.127) or dysarthria (p = 0.238), whereas disorders of the extrapyramidal (p = 0.056) and visual system (p = 0.015) were more common in the younger group. Atypical MRI profiles such as MRI lesions restricted to one hemisphere (p < 0.001) or cortical lesions only (p = 0.258) were found more frequently in patients older than 75 years, whereas typical cortical and basal ganglia hyperintensities were more common in the younger group (p = 0.001). We demonstrated for the first time that patients with late-onset sCJD differ from younger sCJD patients with respect to MRI profiles and initial clinical presentation, but not among CSF markers. Misclassification of Creutzfeldt-Jakob disease cases in patients older than 75 years seems likely due to atypical clinical and radiological presentation. This might contribute to lower sCJD incidence rates in this age group.

Entities:  

Mesh:

Year:  2014        PMID: 24570280     DOI: 10.1007/s00415-014-7283-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  16 in total

1.  Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease.

Authors:  P Parchi; R Castellani; S Capellari; B Ghetti; K Young; S G Chen; M Farlow; D W Dickson; A A Sima; J Q Trojanowski; R B Petersen; P Gambetti
Journal:  Ann Neurol       Date:  1996-06       Impact factor: 10.422

Review 2.  Creutzfeldt-Jakob disease in the elderly.

Authors:  R de Silva; C Findlay; I Awad; R Harries-Jones; R Knight; R Will
Journal:  Postgrad Med J       Date:  1997-09       Impact factor: 2.401

3.  Genetic prion disease: the EUROCJD experience.

Authors:  Gábor G Kovács; Maria Puopolo; Anna Ladogana; Maurizio Pocchiari; Herbert Budka; Cornelia van Duijn; Steven J Collins; Alison Boyd; Antonio Giulivi; Mike Coulthart; Nicole Delasnerie-Laupretre; Jean Philippe Brandel; Inga Zerr; Hans A Kretzschmar; Jesus de Pedro-Cuesta; Miguel Calero-Lara; Markus Glatzel; Adriano Aguzzi; Matthew Bishop; Richard Knight; Girma Belay; Robert Will; Eva Mitrova
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

4.  The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies.

Authors:  G Hsich; K Kenney; C J Gibbs; K H Lee; M G Harrington
Journal:  N Engl J Med       Date:  1996-09-26       Impact factor: 91.245

Review 5.  Sporadic human prion diseases: molecular insights and diagnosis.

Authors:  Gianfranco Puoti; Alberto Bizzi; Gianluigi Forloni; Jiri G Safar; Fabrizio Tagliavini; Pierluigi Gambetti
Journal:  Lancet Neurol       Date:  2012-07       Impact factor: 44.182

6.  Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease.

Authors:  I Zerr; M Bodemer; O Gefeller; M Otto; S Poser; J Wiltfang; O Windl; H A Kretzschmar; T Weber
Journal:  Ann Neurol       Date:  1998-01       Impact factor: 10.422

7.  Incidence and risk of dementia. The Rotterdam Study.

Authors:  A Ott; M M Breteler; F van Harskamp; T Stijnen; A Hofman
Journal:  Am J Epidemiol       Date:  1998-03-15       Impact factor: 4.897

Review 8.  [Creutzfeldt-Jakob disease in patients before and after 80 years of age].

Authors:  Jean-Philippe Brandel; Dominique Salomon; Jean-Jacques Hauw; Stéhane Haïk; Annick Alpérovitch
Journal:  Psychol Neuropsychiatr Vieil       Date:  2008-09

9.  Isolated cortical signal increase on MR imaging as a frequent lesion pattern in sporadic Creutzfeldt-Jakob disease.

Authors:  B Meissner; K Kallenberg; P Sanchez-Juan; A Krasnianski; U Heinemann; D Varges; M Knauth; I Zerr
Journal:  AJNR Am J Neuroradiol       Date:  2008-07-03       Impact factor: 3.825

10.  Human prion diseases in the United States.

Authors:  Robert C Holman; Ermias D Belay; Krista Y Christensen; Ryan A Maddox; Arialdi M Minino; Arianne M Folkema; Dana L Haberling; Teresa A Hammett; Kenneth D Kochanek; James J Sejvar; Lawrence B Schonberger
Journal:  PLoS One       Date:  2010-01-01       Impact factor: 3.240

View more
  5 in total

1.  Clinical findings and diagnosis in genetic prion diseases in Germany.

Authors:  Anna Krasnianski; Uta Heinemann; Claudia Ponto; Jasmine Kortt; Kai Kallenberg; Daniela Varges; Walter J Schulz-Schaeffer; Hans A Kretzschmar; Inga Zerr
Journal:  Eur J Epidemiol       Date:  2015-06-16       Impact factor: 8.082

2.  Creutzfeldt-Jakob Disease in Nonagenarian: A Rare Presentation from India.

Authors:  Shubhakaran P Khichar; Nirav L Sutariya; Amita N Bhargava; Sangeeta R Pradhan
Journal:  Ann Indian Acad Neurol       Date:  2021-12-14       Impact factor: 1.383

3.  Creutzfeldt-Jakob Disease: In-hospital demographics report of national data in the United States from 2016 and review of a rapidly-progressive case.

Authors:  Eithan Kotkowski; John H Cabot; John V Lacci; Davis H Payne; Jose E Cavazos; Rebecca S Romero; Ali Seifi
Journal:  Clin Neurol Neurosurg       Date:  2020-07-22       Impact factor: 1.876

Review 4.  Biomarkers for sporadic Creutzfeldt-Jakob disease.

Authors:  Sanam Soomro; Chandra Mohan
Journal:  Ann Clin Transl Neurol       Date:  2016-04-25       Impact factor: 4.511

5.  An enigmatic case of cortical anopsia: Antemortem diagnosis of a 14-3-3 negative Heidenhain-variant MM1-sCJD.

Authors:  Julius Obergassel; Lisa Lohmann; Sven G Meuth; Heinz Wiendl; Oliver Grauer; Christopher Nelke
Journal:  Prion       Date:  2020-12       Impact factor: 3.931

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.